BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 128,338,000 | $101,094,132 | 3.30% |
| Affinity Asset Advisors, LLC | 12,000,000 | $9,452,614 | 3.30% |
| ARISTEIA CAPITAL, L.L.C. | 157,723,000 | $124,241,221 | 2.76% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $6,653,102 | 1.79% |
| TFG Asset Management GP Ltd | 10,000,000 | $7,848,611 | 1.06% |
| 683 Capital Management, LLC | 12,250,000 | $9,608,655 | 0.69% |
| Context Capital Management, LLC | 8,785 | $6,920 | 0.63% |
| Weiss Asset Management LP | 10,000,000 | $7,814,740 | 0.60% |
| MACKAY SHIELDS LLC | 14,404,000 | $11,346,287 | 0.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7,500,000 | $5,882,850 | 0.26% |